黴菌毒素檢測市場 - 全球產業規模、佔有率、趨勢、機會及預測（按類型、技術、樣本、最終用戶、地區和競爭格局分類，2021-2031年）

全球黴菌毒素檢測市場預計將從 2025 年的 144.6 億美元成長到 2031 年的 223.9 億美元，複合年成長率為 7.56%。

黴菌毒素檢測是指用於識別和測量農作物和加工食品中真菌產生的有毒次級代謝物的分析通訊協定。該市場的成長主要受嚴格的國際食品安​​全標準和不斷成長的全球貿易量驅動，這些標準和貿易量要求嚴格遵守最大殘留基準值。此外，氣候條件不穩定導致真菌污染日益頻繁，也是推動常規檢測措施實施的關鍵因素。

儘管市場需求強勁，但先進層析法設備所需的高額資本投入以及複雜的樣品製備過程，對發展中地區的市場成長構成了重大障礙。準確的數據對於有效的風險管理策略仍然至關重要。正如2024年發布的《2023年預警與合作網路年度報告》所述，黴菌毒素仍然是一個重要的安全隱患，歐洲網路共記錄了401起相關報告，使其成為報告數量第三多的危險物質類別。

市場促進因素

氣候變遷對作物黴菌易感性的影響日益加劇，是全球黴菌毒素檢測市場的主要促進因素。從長期乾旱到暴雨等極端天氣事件，為農產品中真菌的生長創造了理想條件，因此需要更頻繁、更全面的分析。隨著供應鏈面臨日益成長的污染風險，該行業依賴數據來預測和管理這些生物危害。根據帝斯曼-菲美意公司於2025年3月發布的《全球黴菌毒素調查報告》，六種主要黴菌毒素的檢出率上年度上升，北美和南亞等地區被列為「極高」風險等級。這迫使生產商實施嚴格的篩檢，以確保原料在加工過程中保持安全。

對高品質飼料日益成長的需求以及減少收穫後污染造成的經濟損失的迫切需要，進一步推動了市場對相關技術的應用。多種毒素同時存在（即黴菌毒素共存）會對牲畜構成嚴重的健康風險，因此，為了維持畜群生產力，人們開始轉向採用先進的多毒素檢測方法。嘉吉公司在2025年3月世界黴菌毒素論壇上發布的《全球黴菌毒素報告》顯示，黴菌毒素共存仍是一個重大挑戰，在78%的受檢飼料樣本中檢測到三種或三種以上的黴菌毒素。這項業務需求為檢測服務提供者帶來了顯著的財務效益。根據Neogen公司2025年的數據顯示，食品安全部門的收入占公司年度總收入的71.3%，證實了該行業的強勁商業性成長。

市場挑戰

先進層析法設備所需的巨額資本投入，構成了全球黴菌毒素檢測市場擴張的一大結構性障礙。液相層析法質譜儀等尖端檢測系統對於達到識別微量污染所需的靈敏度至關重要。然而，這項技術高昂的購買和營運成本，對小規模實驗室和食品加工企業，尤其是在開發中國家，構成了很高的進入門檻。這種經濟負擔限制了自動化檢測通訊協定的應用，使其僅限於已開發國家資源充足的機構，從而有效地抑制了新興市場的需求，而這些新興市場往往面臨最大的真菌污染風險。

此外，樣品製備的複雜性需要專用設備和高技能人員，這增加了營運成本。這種技術上的獨佔性使得小規模農業相關企業無法進行常規的內部檢測，迫使它們依賴第三方服務或乾脆放棄檢測。貿易合規數據也印證了這種嚴格且高成本的檢測需求。根據美國穀物協會發布的《2024年玉米作物品質報告》，98.9%的受檢樣本符合聯邦政府嚴格的黃麴毒素基準值。這種以金額為準的精確合規性確認需要精密的設備，而這些設備對於許多市場參與企業來說仍然遙不可及，從而限制了檢測解決方案的潛在市場規模。

市場趨勢

對新興和隱藏黴菌毒素的監測力道加大，正從根本上重塑市場分析策略。監管機構和行業相關人員正在擴大檢測範圍，超越傳統的受監管化合物，以檢測標準篩檢常常遺漏的變異株和鮮為人知的真菌代謝物。這種轉變的驅動力在於，人們需要全面了解飼料和食品基質的毒理學負擔，尤其是在非管制毒素日益普遍的情況下。根據專利公司於2025年2月進行的“2024年收成調查”，從多個歐洲國家採集的玉米樣本100%都受到多種黴菌毒素的污染，除了受監管的化合物外，新興毒素（例如博維菌素）也被確定為主要污染物。

同時，檢測資料的數位化和可追溯性的建立正成為應對供應鏈安全複雜性的關鍵趨勢。檢測實驗室和食品加工商正在加速整合人工智慧和雲端平台，以匯總檢測結果、預測污染風險並確保即時合規。這項技術變革正推動產業從被動偵測轉向主動風險情報，從而在問題出現時能夠更快地做出決策。根據SGS於2025年2月發布的《Digicomply威脅情報洞察報告》，在過去24個月中，黴菌毒素一直位列全球報告的三大食品安全危害之一，這凸顯了人們越來越依賴數位化工具來監測這些生物威脅。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球黴菌毒素檢測市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依類型（黃麴毒素、Deoxynivalenol、赭曲毒素、Fumonisins、其他）
  • 依技術分類（基於高效液相層析法、基於液相層析-串聯質譜法、基於免疫檢測、其他）
  • 按樣本（食品、飼料）
  • 按最終用戶（研究實驗室、研究機構、食品檢測產業、飼料檢測產業等）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

6. 北美黴菌毒素檢測市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

7. 歐洲黴菌毒素檢測市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

8. 亞太地區黴菌毒素檢測市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東和非洲黴菌毒素檢測市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

10. 南美黴菌毒素檢測市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球黴菌毒素檢測市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• SGS Societe Generale de Surveillance SA.
• Bureau Veritas
• Eurofins Scientific
• Intertek Group plc
• Merieux NutriSciences Corporation
• ALS Limited
• Neogen Corporation
• AsureQuality Limited.
• Charm Sciences, Inc.
• Premier Analytical Services

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Mycotoxin Testing Market is projected to expand from USD 14.46 Billion in 2025 to USD 22.39 Billion by 2031, reflecting a compound annual growth rate of 7.56%. Mycotoxin testing involves the analytical protocols used to identify and measure toxic secondary metabolites generated by fungi in agricultural crops and processed foods. The market is primarily driven by the implementation of rigorous international food safety standards and the increasing volume of global trade, which mandates strict adherence to maximum residue limits. Furthermore, the rising frequency of fungal contamination caused by unstable climate conditions acts as a key catalyst for the adoption of routine testing measures.

Despite strong demand, the substantial capital required for advanced chromatographic equipment and the complexity of sample preparation pose major hurdles to market growth in developing regions. Accurate data remains essential for effective risk management strategies. As noted in the Alert and Cooperation Network 2023 Annual Report released in 2024, mycotoxins continued to be a significant safety concern, ranking as the third most reported hazard category with 401 notifications documented across the European network.

Market Driver

The intensifying impact of climate change on crop vulnerability to mold serves as a primary driver for the Global Mycotoxin Testing Market. Extreme weather patterns, ranging from prolonged droughts to excessive rainfall, create ideal conditions for fungal proliferation in agricultural commodities, necessitating more frequent and comprehensive analysis. As supply chains face elevated contamination risks, the industry relies on data to forecast and manage these biological hazards. According to the 'World Mycotoxin Survey' by dsm-firmenich in March 2025, the prevalence of all six major mycotoxins increased compared to the previous year, with risk levels classified as extreme in regions such as North America and South Asia, compelling producers to adopt strict screening to ensure raw materials remain safe for processing.

The rising demand for high-quality animal feed and the critical need to mitigate economic losses from post-harvest contamination further stimulate market adoption. Mycotoxin co-occurrence-where multiple toxins exist simultaneously-poses severe health risks to livestock, driving the shift toward advanced multi-toxin detection methods to preserve herd productivity. Findings from the 'World Mycotoxin Report' presented by Cargill at the World Mycotoxin Forum in March 2025 highlight that co-occurrence remains a major challenge, with 78% of tested feed samples containing three or more mycotoxins. This operational necessity drives significant financial performance for testing providers; according to Neogen Corporation in 2025, the Food Safety segment contributed 71.3% of the company's total annual revenues, underscoring the sector's robust commercial expansion.

Market Challenge

The substantial capital investment required for sophisticated chromatographic instruments constitutes a significant structural impediment to the broader expansion of the global mycotoxin testing market. State-of-the-art detection systems, such as liquid chromatography-mass spectrometry, are essential for achieving the sensitivity needed to identify trace contamination levels. However, the high procurement and operational costs associated with this technology create a steep entry barrier for small-scale laboratories and food processors, particularly in developing economies. This financial burden restricts the adoption of automated testing protocols to well-funded organizations in industrialized nations, effectively stifling demand in emerging markets where the risk of fungal contamination is often highest.

Additionally, the complexity of sample preparation demands specialized infrastructure and highly skilled personnel, which adds to the operational expenditure. This technical exclusivity prevents smaller agricultural entities from implementing routine internal testing, forcing them to rely on third-party services or forgo testing entirely. The necessity for such rigorous, high-cost testing is evident in trade compliance data. According to the U.S. Grains Council's 2024 Corn Harvest Quality Report, 98.9% of tested samples met strict federal action levels for aflatoxin. Verifying compliance at such precise thresholds requires sophisticated instrumentation that remains financially inaccessible to many market participants, thereby capping the total addressable market for testing solutions.

Market Trends

The increased surveillance of emerging and masked mycotoxins is fundamentally reshaping analytical strategies within the market. Regulatory bodies and industry players are expanding testing panels beyond traditional regulated compounds to detect modified forms and lesser-known fungal metabolites that standard screening often misses. This shift is driven by the need to understand the full toxicological burden of feed and food matrices, particularly as non-regulated toxins become more prevalent. According to the '2024 Harvest Survey' by Patent Co in February 2025, 100% of corn samples analyzed from multiple European nations were contaminated with more than one mycotoxin type, with emerging toxins such as beauvericin identified as primary contaminants alongside regulated compounds.

Concurrently, the digitalization of testing data and traceability is emerging as a critical trend to manage the complexity of supply chain safety. Laboratories and food processors are increasingly integrating artificial intelligence and cloud-based platforms to aggregate testing results, predict contamination risks, and ensure real-time regulatory compliance. This technological transition moves the industry from reactive testing to proactive risk intelligence, allowing for faster decision-making during outbreaks. According to SGS in its 'Digicomply' risk intelligence insights from February 2025, mycotoxins persisted as one of the top three reported food safety hazards globally over the preceding 24 months, underscoring the reliance on digital tools to monitor these biological threats.

Key Market Players

• SGS Societe Generale de Surveillance SA.
• Bureau Veritas
• Eurofins Scientific
• Intertek Group plc
• Merieux NutriSciences Corporation
• ALS Limited
• Neogen Corporation
• AsureQuality Limited.
• Charm Sciences, Inc.
• Premier Analytical Services

Report Scope

In this report, the Global Mycotoxin Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Mycotoxin Testing Market, By Type

• Aflatoxin
• Deoxynivalenol
• Ochratoxins
• Fumonisins
• Others

Mycotoxin Testing Market, By Technology

• HPLC-based
• LC-MS/MS-based
• Immunoassay-based
• Others

Mycotoxin Testing Market, By Sample

• Food
• Feed

Mycotoxin Testing Market, By End User

• Research Lab
• Research Institutes
• Food Testing Industries
• Feed Testing Industries
• Others

Mycotoxin Testing Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Mycotoxin Testing Market.

Available Customizations:

Global Mycotoxin Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Mycotoxin Testing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Aflatoxin, Deoxynivalenol, Ochratoxins, Fumonisins, Others)
  • 5.2.2. By Technology (HPLC-based, LC-MS/MS-based, Immunoassay-based, Others)
  • 5.2.3. By Sample (Food, Feed)
  • 5.2.4. By End User (Research Lab, Research Institutes, Food Testing Industries, Feed Testing Industries, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Mycotoxin Testing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Technology
  • 6.2.3. By Sample
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Mycotoxin Testing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Sample
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Mycotoxin Testing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Sample
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Mycotoxin Testing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Sample
      • 6.3.3.2.4. By End User

7. Europe Mycotoxin Testing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Technology
  • 7.2.3. By Sample
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Mycotoxin Testing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Sample
      • 7.3.1.2.4. By End User
  • 7.3.2. France Mycotoxin Testing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Sample
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Mycotoxin Testing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Sample
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Mycotoxin Testing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Sample
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Mycotoxin Testing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Sample
      • 7.3.5.2.4. By End User

8. Asia Pacific Mycotoxin Testing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Technology
  • 8.2.3. By Sample
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Mycotoxin Testing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Sample
      • 8.3.1.2.4. By End User
  • 8.3.2. India Mycotoxin Testing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Sample
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Mycotoxin Testing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Sample
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Mycotoxin Testing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Sample
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Mycotoxin Testing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Sample
      • 8.3.5.2.4. By End User

9. Middle East & Africa Mycotoxin Testing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Technology
  • 9.2.3. By Sample
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Mycotoxin Testing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Sample
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE Mycotoxin Testing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Sample
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa Mycotoxin Testing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Sample
      • 9.3.3.2.4. By End User

10. South America Mycotoxin Testing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Technology
  • 10.2.3. By Sample
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Mycotoxin Testing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Sample
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia Mycotoxin Testing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Sample
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina Mycotoxin Testing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Sample
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Mycotoxin Testing Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. SGS Societe Generale de Surveillance SA.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Bureau Veritas
• 15.3. Eurofins Scientific
• 15.4. Intertek Group plc
• 15.5. Merieux NutriSciences Corporation
• 15.6. ALS Limited
• 15.7. Neogen Corporation
• 15.8. AsureQuality Limited.
• 15.9. Charm Sciences, Inc.
• 15.10. Premier Analytical Services

16. Strategic Recommendations

17. About Us & Disclaimer